Kestra Advisory Services LLC Purchases 4,321 Shares of Cigna Group $CI

Kestra Advisory Services LLC boosted its position in shares of Cigna Group (NYSE:CI) by 15.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,601 shares of the health services provider’s stock after acquiring an additional 4,321 shares during the period. Kestra Advisory Services LLC’s holdings in Cigna Group were worth $8,590,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Osbon Capital Management LLC bought a new position in Cigna Group in the 2nd quarter valued at $26,000. Putney Financial Group LLC bought a new position in shares of Cigna Group in the third quarter worth $27,000. Johnson Financial Group Inc. bought a new position in shares of Cigna Group in the second quarter worth $29,000. Fiduciary Financial Advisors purchased a new stake in shares of Cigna Group in the second quarter worth $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Cigna Group in the second quarter worth $34,000. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In related news, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Royal Bank Of Canada restated an “outperform” rating and set a $337.00 target price on shares of Cigna Group in a research report on Thursday, October 1st. UBS Group restated a “buy” rating on shares of Cigna Group in a research note on Thursday, October 1st. Robert W. Baird set a $362.00 price target on Cigna Group in a report on Friday, July 31st. Sanford C. Bernstein reiterated an “outperform” rating on shares of Cigna Group in a research report on Friday, October 2nd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Fourteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $336.20.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Recent coverage says strong Q3 growth has lifted Cigna’s 2026 earnings outlook, offering a favorable signal about business performance and the company’s earnings trajectory. The Cigna Group stock: Higher outlook follows strong Q3 performance
• Positive Sentiment: Barclays raised its price target to $320 from $310, implying potential upside from the referenced $302.30 price. However, it maintained an “equal weight” rating, indicating a balanced rather than strongly bullish view. Barclays price target update
• Neutral Sentiment: The Cigna Group Foundation awarded $3.45 million to 23 nonprofits supporting housing stability and mental health for veterans and their families. This highlights community investment but is not likely to have a significant direct effect on earnings. Cigna Foundation veteran grants
• Neutral Sentiment: Cigna’s CFO is scheduled to speak at the UBS Global Healthcare Conference, which could provide investors with updates but is not itself a financial announcement. UBS Global Healthcare Conference appearance
• Neutral Sentiment: Cigna Healthcare Hong Kong is expanding access to Headspace’s self-guided mental-wellbeing resources. The partnership may support its service offering, though the report provides no financial impact. Headspace resources in Hong Kong
• Negative Sentiment: Guggenheim cut its price target for Cigna, a cautious counterpoint to Barclays’ increase. The report provided here does not specify the revised target or rating. Guggenheim price target update

Cigna Group Stock Performance

NYSE CI opened at $302.30 on Wednesday. Cigna Group has a 52-week low of $257.85 and a 52-week high of $318.05. The company has a fifty day moving average of $286.66 and a 200-day moving average of $282.38. The company has a market capitalization of $79.88 billion, a P/E ratio of 13.34, a P/E/G ratio of 1.10 and a beta of 0.25. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The business had revenue of $73.79 billion for the quarter, compared to analysts’ expectations of $72.64 billion. During the same quarter in the prior year, the firm earned $7.83 earnings per share. The firm’s revenue was up 5.6% on a year-over-year basis. As a group, equities research analysts predict that Cigna Group will post 30.70 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio is 27.54%.

Cigna Group Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.